Fingerprint
Dive into the research topics of 'Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
Jesus Vera Aguilera, Jonas Paludo, Robert R. Mcwilliams, Henan Zhang, Ying Li, Anagha B. Kumar, Jarrett Failing, Lisa A. Kottschade, Matthew S. Block, Svetomir N. Markovic, Haidong Dong, Roxana S. Dronca, Yiyi Yan
Research output: Contribution to journal › Article › peer-review
6
Scopus
citations